241 related articles for article (PubMed ID: 22388842)
41. U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease.
Scarisbrick JJ; Taylor P; Holtick U; Makar Y; Douglas K; Berlin G; Juvonen E; Marshall S;
Br J Dermatol; 2008 Apr; 158(4):659-78. PubMed ID: 18241274
[TBL] [Abstract][Full Text] [Related]
42. Long-term extracorporeal photochemotherapy in a pediatric patient with refractory sclerodermatous chronic graft-versus-host disease.
Bisaccia E; Palangio M; Gonzalez J
Transfus Apher Sci; 2011 Oct; 45(2):187-90. PubMed ID: 21890415
[TBL] [Abstract][Full Text] [Related]
43. Feasibility and safety of a new technique of extracorporeal photochemotherapy: experience of 240 procedures.
Perotti C; Torretta L; Viarengo G; Roveda L; Bernuzzi S; Carbone S; Del Fante C; La Torre R; Locatelli F; Bonetti F; Gabba P; Bellosta M; Salvaneschi L
Haematologica; 1999 Mar; 84(3):237-41. PubMed ID: 10189389
[TBL] [Abstract][Full Text] [Related]
44. Prospective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and survival incorporating prognostic factors.
Foss FM; DiVenuti GM; Chin K; Sprague K; Grodman H; Klein A; Chan G; Stiffler K; Miller KB
Bone Marrow Transplant; 2005 Jun; 35(12):1187-93. PubMed ID: 15852025
[TBL] [Abstract][Full Text] [Related]
45. Extracorporeal photochemotherapy for graft versus host disease in pediatric patients.
Kanold J; Paillard C; Halle P; D'Incan M; Bordigoni P; Deméocq F
Transfus Apher Sci; 2003 Feb; 28(1):71-80. PubMed ID: 12620271
[TBL] [Abstract][Full Text] [Related]
46. Cutaneous T-cell lymphoma and cutaneous graft-versus-host disease. Two indications for photopheresis in dermatology.
Girardi M; Heald PW
Dermatol Clin; 2000 Jul; 18(3):417-23, viii. PubMed ID: 10943537
[TBL] [Abstract][Full Text] [Related]
47. Extracorporeal photoimmunotherapy for the treatment of steroid refractory progressive chronic graft-versus-host disease.
Ilhan O; Arat M; Arslan O; Ayyildiz E; Sanli H; Beksac M; Ozcan M; Gürman G; Akan H
Transfus Apher Sci; 2004 Jun; 30(3):185-7. PubMed ID: 15172621
[TBL] [Abstract][Full Text] [Related]
48. Recent advances in phototherapy.
Simon JC; Pfieger D; Schöpf E
Eur J Dermatol; 2000 Dec; 10(8):642-5. PubMed ID: 11125334
[TBL] [Abstract][Full Text] [Related]
49. Miscellaneous indications for extracorporeal photochemotherapy (ECP).
Andreu-Ullrich H
Transfus Apher Sci; 2014 Jun; 50(3):363-9. PubMed ID: 24816437
[TBL] [Abstract][Full Text] [Related]
50. Cutaneous T cell lymphoma and graft-versus-host disease: a comparison of in vivo effects of extracorporeal photochemotherapy on Foxp3+ regulatory T cells.
Rao V; Saunes M; Jørstad S; Moen T
Clin Immunol; 2009 Dec; 133(3):303-13. PubMed ID: 19773201
[TBL] [Abstract][Full Text] [Related]
51. Identification of amplified clonal T cell populations in the blood of patients with chronic graft-versus-host disease: positive correlation with response to photopheresis.
French LE; Alcindor T; Shapiro M; McGinnis KS; Margolis DJ; Porter D; Leonard DG; Rook AH; Foss F
Bone Marrow Transplant; 2002 Oct; 30(8):509-15. PubMed ID: 12379890
[TBL] [Abstract][Full Text] [Related]
52. [Advances of mechanism study on extracorporeal photochemotherapy to treat and prevent graft-versus-host disease in vitro--review].
Chen Z; Zhao G; Chen BA
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1376-80. PubMed ID: 21129297
[TBL] [Abstract][Full Text] [Related]
53. The role of extracorporeal photopheresis in the management of cutaneous T-cell lymphoma, graft-versus-host disease and organ transplant rejection: a consensus statement update from the UK Photopheresis Society.
Alfred A; Taylor PC; Dignan F; El-Ghariani K; Griffin J; Gennery AR; Bonney D; Das-Gupta E; Lawson S; Malladi RK; Douglas KW; Maher T; Guest J; Hartlett L; Fisher AJ; Child F; Scarisbrick JJ
Br J Haematol; 2017 Apr; 177(2):287-310. PubMed ID: 28220931
[TBL] [Abstract][Full Text] [Related]
54. Extracorporeal photochemotherapy in patients with cutaneous T-cell lymphoma: is clinical response predictable?
Rao V; Ryggen K; Aarhaug M; Dai HY; Jørstad S; Moen T
J Eur Acad Dermatol Venereol; 2006 Oct; 20(9):1100-7. PubMed ID: 16987266
[TBL] [Abstract][Full Text] [Related]
55. Extracorporeal photopheresis in chronic graft-versus-host disease.
Foss FM; Gorgun G; Miller KB
Bone Marrow Transplant; 2002 May; 29(9):719-25. PubMed ID: 12040467
[TBL] [Abstract][Full Text] [Related]
56. Photopheresis in pediatric graft-versus-host disease after allogeneic marrow transplantation: clinical practice guidelines based on field experience and review of the literature.
Kanold J; Merlin E; Halle P; Paillard C; Marabelle A; Rapatel C; Evrard B; Berger C; Stephan JL; Galambrun C; Piguet C; D'Incan M; Bordigoni P; Deméocq F
Transfusion; 2007 Dec; 47(12):2276-89. PubMed ID: 17764513
[TBL] [Abstract][Full Text] [Related]
57. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
Edelson RL
Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
[TBL] [Abstract][Full Text] [Related]
58. Extracorporeal Photopheresis in Dermatological Diseases.
Terhaar H; Saleem M; Yusuf N
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474257
[TBL] [Abstract][Full Text] [Related]
59. Mini buffy coat photopheresis for children and critically ill patients with extracorporeal photopheresis contraindications.
Hackstein H; Misterek J; Nockher A; Reiter A; Bein G; Woessmann W
Transfusion; 2009 Nov; 49(11):2366-73. PubMed ID: 19903292
[TBL] [Abstract][Full Text] [Related]
60. Extracorporeal photochemotherapy: a case report and update.
Knobler E; Warmuth I
Cutis; 2002 Feb; 69(2):119-23. PubMed ID: 11868976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
